Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sujatha Sanjeevi & Angela Cocoman. (2021) Mental Health Nurses' Knowledge of Clozapine. Issues in Mental Health Nursing 42:3, pages 291-298.
Read now
Read now
Hamza Ayaydın & Şermin Bilgen Ulgar. (2019) Control of seizures in a clozapine-treated schizophrenia patient, using valproate: a case report. Psychiatry and Clinical Psychopharmacology 29:4, pages 529-532.
Read now
Read now
Articles from other publishers (27)
Hua-Rong Lu, Manabu Seo, Mohamed Kreir, Tetsuya Tanaka, Rie Yamoto, Cristina Altrocchi, Karel van Ammel, Fetene Tekle, Ly Pham, Xiang Yao, Ard Teisman & David J. Gallacher. (2023) High-Throughput Screening Assay for Detecting Drug-Induced Changes in Synchronized Neuronal Oscillations and Potential Seizure Risk Based on Ca2+ Fluorescence Measurements in Human Induced Pluripotent Stem Cell (hiPSC)-Derived Neuronal 2D and 3D Cultures. Cells 12:6, pages 958.
Crossref
Crossref
Abhinav Chichra, Niji Rachel VarugheseRaviteja Innamuri. (2022) De Novo Seizures, Obsessive Compulsive Symptoms and Neutropenias in Patients on Clozapine: A Retrospective Cohort Study. Indian Journal of Psychological Medicine 45:1, pages 33-37.
Crossref
Crossref
Ranel Troy Santos, Sandra Mullen, Ericka L. Crouse & Katie S. Adams. (2022) Comparison of clozapine doses and tolerability in patients with and without concurrent valproic acid. Mental Health Clinician 12:6, pages 336-341.
Crossref
Crossref
Yuta Kawakita, Masahiro Takeshima, Tomonari Komatsu, Aya Imanishi, Dai Fujiwara, Yu Itoh & Kazuo Mishima. (2022) Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study. BMC Psychiatry 22:1.
Crossref
Crossref
Nicolas Raymond, Paulo Lizano, Sinead Kelly, Rachal Hegde, Sarah Keedy, Godfrey D. Pearlson, Elliot S. Gershon, Brett A. Clementz, Carol A. Tamminga & Matcheri Keshavan. (2022) What can clozapine’s effect on neural oscillations tell us about its therapeutic effects? A scoping review and synthesis. Biomarkers in Neuropsychiatry 6, pages 100048.
Crossref
Crossref
TAMAR TSENTERADZE, GIORGI KOCHIASHVILI, MARIAM GABADADZE, DAVIT KALMAKHELIDZE & ZURAB ZAALISHVILI. (2022) SELECTED NEUROLOGIC AND PSYCHIATRIC OUTCOMES IN PATIENTS TREATED WITH CLOZAPIN (Review Article). EXPERIMENTAL & CLINICAL MEDICINE GEORGIA.
Crossref
Crossref
Deeba Nazir, Zaid Ahmad Wani, Fahd Bukhari, Shabir Ahmad Dar & Yuman Kawoosa. (2021) Socio demographic, clinical, and side effect profile of patients on clozapine in Kashmir, North India. Middle East Current Psychiatry 28:1.
Crossref
Crossref
Kouji Fukuyama & Motohiro Okada. (2021) Effects of an Atypical Antipsychotic, Zotepine, on Astroglial L-Glutamate Release through Hemichannels: Exploring the Mechanism of Mood-Stabilising Antipsychotic Actions and Antipsychotic-Induced Convulsion. Pharmaceuticals 14:11, pages 1116.
Crossref
Crossref
Dan-Sheng Le, Heng Su, Zheng-Luan Liao & En-Yan Yu. (2021) Low-dose clozapine-related seizure: A case report and literature review. World Journal of Clinical Cases 9:20, pages 5611-5620.
Crossref
Crossref
Allison Schmitz, Brandon Botner & Morris Hund. (2020) Bupropion With Clozapine: Case Reports of Seizure After Coadministration. Journal of Pharmacy Practice 34:3, pages 497-502.
Crossref
Crossref
Masahiro Hata, Michiko Fujimoto, Koji Kanai, Kenji Yoshiyama, Yoshitaka Nakatani, Daiji Nakabayashi, Saki Maemura, Shinya Kawata, Takaaki Hakozaki, Shuya Nishikura, Aiko Umemoto, Toru Sasada, Kazuhiko Iwata, Hideki Tanaka, Akiko Mamoto, Yuuki Toi, Norio Taniguchi, Makiko Saito, Yoshio Kimura, Kazuko Kishimoto, Megumi Hayami & Manabu Ikeda. (2021) No adverse events were observed in clozapine‐treated patients on extended hematologic monitoring intervals during the coronavirus pandemic in four psychiatric centers in Japan. Neuropsychopharmacology Reports 41:2, pages 179-184.
Crossref
Crossref
B. de Toffol, N. Adachi, K. Kanemoto, W. El-Hage & C. Hingray. (2020) Les psychoses épileptiques interictales. L'Encéphale 46:6, pages 482-492.
Crossref
Crossref
Ana Dragoi, Ioana Radulescu, Bogdana Năsui, Anca Pop, Valentin Varlas & Simona Trifu. (2020) Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19. Brain Sciences 10:11, pages 840.
Crossref
Crossref
Motohiro Okada, Kouji Fukuyama, Takashi Shiroyama & Masahiko Murata. (2020) A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43. International Journal of Molecular Sciences 21:19, pages 7019.
Crossref
Crossref
Ermal Bojdani, Anderson Chen, Stefania Buonocore, Kevin J. Li & Ronald Gurrera. (2019) Meloxicam-desmopressin drug-drug interaction producing hyponatremia. Psychiatry Research 279, pages 284-286.
Crossref
Crossref
Anvesh Jackson & Udaya Seneviratne. (2019) EEG changes in patients on antipsychotic therapy: A systematic review. Epilepsy & Behavior 95, pages 1-9.
Crossref
Crossref
Hye Sung Kim, Tak Youn, Se Hyun Kim, Seong Hoon Jeong, Hee Yeon Jung, Sang-Wuk Jeong, Kwang Ki Kim, Yong Sik Kim & In Won Chung. (2019) Association between electroencephalogram changes and plasma clozapine levels in clozapine-treated patients. International Clinical Psychopharmacology 34:3, pages 131-137.
Crossref
Crossref
AnkurJyoti Borah, Abhijit Kalita & SatyaKumar Dutta. (2019) Clozapine-induced seizure. Indian Journal of Pharmacology 51:6, pages 410.
Crossref
Crossref
Bertrand de Toffol, Michael Trimble, Dale C. Hesdorffer, Lauren Taylor, Perminder Sachdev, Maurice Clancy, Naoto Adachi, José Augusto Bragatti, Marco Mula & Kousuke Kanemoto. (2018) Pharmacotherapy in patients with epilepsy and psychosis. Epilepsy & Behavior 88, pages 54-60.
Crossref
Crossref
Marvin Villacrez, Karin Hellman, Tatsuya Ono, Yutaka Sugihara, Melinda Rezeli, Fredrik Ek, Gyorgy Marko-Varga & Roger Olsson. (2018) Evaluation of Drug Exposure and Metabolism in Locust and Zebrafish Brains Using Mass Spectrometry Imaging. ACS Chemical Neuroscience 9:8, pages 1994-2000.
Crossref
Crossref
Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Domenico Di Nicola, Carmine Tomasetti, Alessandro Valchera, Michele Fornaro, Fabio Di Fabio, Giampaolo Perna, Marco Di Nicola, Gianluca Serafini, Alessandro Carano, Maurizio Pompili, Federica Vellante, Laura Orsolini, Giovanni Martinotti & Massimo Di Giannantonio. (2018) Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Therapeutic Advances in Drug Safety 9:5, pages 237-256.
Crossref
Crossref
Abdullah Bolu, Süleyman Akarsu, Erdal Pan, Emre Aydemir & Taner Oznur. (2017) Low-dose Clozapine-induced Seizure: A Case Report. Clinical Psychopharmacology and Neuroscience 15:2, pages 190-193.
Crossref
Crossref
Vanessa Suazo, Alba Lubeiro, Rosa Jurado-Barba, Marta Moreno-Ortega, Mónica Dompablo, Isabel Morales-Muñoz, Roberto Rodriguez-Jimenez, Tomas Palomo & Vicente Molina. (2016) Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients. European Archives of Psychiatry and Clinical Neuroscience 266:8, pages 743-753.
Crossref
Crossref
B. de Toffol & K. Kanemoto. (2016) Clinique et neurobiologie des psychoses post-ictales. L'Encéphale 42:5, pages 443-447.
Crossref
Crossref
Elias Mouchlianitis, Robert McCutcheon & Oliver D Howes. (2016) Brain-imaging studies of treatment-resistant schizophrenia: a systematic review. The Lancet Psychiatry 3:5, pages 451-463.
Crossref
Crossref
. (2015) Clozapine. Reactions Weekly 1560:1, pages 62-62.
Crossref
Crossref
P. Chue & G. Baker. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
63
83
.